BridgeBio Pharma, Inc., San Francisco, CA, USASan Francisco, California, United States
Disclosure information not submitted.
MON-759 - Patient Experience and Diagnostic Journey in Autosomal Dominant Hypocalcemia Type 1: Insights from in-Depth Patient Surveys
Monday, June 15, 20269:00 AM - 2:00 PM CT